This manifested as increased ALT levels, worsened liver steatosis, Sirius Red-positive area for fibrotic fibers, cell death, and increased MASH-related gene expression without body weight differences, compared to those of the littermate control Chrna2fl/fl mice (Fig 3I–3N and S6G). The gene discussed is GPT; the disease is fatty liver disease.